Medivirs CMO to BioStock: “Our new clinical data are very encouraging”
Medivir presents the first clinical data with fostrox + Lenvima at the ASCO GI scientific congress, showing further improved clinical benefit vs previous interim updates from the ongoing phase Ib/IIa study in advanced hepatocellular carcinoma. According to the company, the data supports the planning for a pivotal phase IIb study in 2024. BioStock reached out to Pia Baumann, Medivir’s CMO, to learn more about the new data.Read the full interview with Pia Baumann at biostock.se: https://www.biostock.se/en/2024/01/medivirs-cmo-our-new-clinical-data-are-very-encouraging/ This is a press
Today’s electrical motors are generally made by cutting and moulding pieces from a metal sheet. 3D printing can radically increase efficiency and reduce material consumption. 3D printing larger motor parts has proven difficult, however, as the parts become too brittle and may easily break. Through an EU-funded project together with research- and customer partners, Elkem has developed a new specialized iron silicon powder, which may allow 3D-printing of components for electrical motors.In the SOMA project (Lightweight solutions for e-mobility by AM for soft magnetic alloys), Elkem together